Patents by Inventor Nikolai V. Ravin

Nikolai V. Ravin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Linear vectors, host cells and cloning methods
    Patent number: 9765343
    Abstract: Linear vectors derived from bacteriophage of E. coli and host cells suitable for cloning are provided. The linear vectors include a left arm comprising a left telomere and a first selectable marker, a right arm comprising a right telomere and a second selectable marker and a cloning region located between the left arm and the right arm. Optional further components of the vector include transcriptional termination sequences, multiple cloning sites and reporter stuffer regions.
    Type: Grant
    Filed: April 8, 2015
    Date of Patent: September 19, 2017
    Assignee: LUCIGEN CORPORATION
    Inventors: Ronald Godiska, David A. Mead, Nikolai V. Ravin
  • LINEAR VECTORS, HOST CELLS AND CLONING METHODS
    Publication number: 20150218565
    Abstract: Linear vectors derived from bacteriophage of E. coli and host cells suitable for cloning are provided. The linear vectors include a left arm comprising a left telomere and a first selectable marker, a right arm comprising a right telomere and a second selectable marker and a cloning region located between the left arm and the right arm. Optional further components of the vector include transcriptional termination sequences, multiple cloning sites and reporter stuffer regions.
    Type: Application
    Filed: April 8, 2015
    Publication date: August 6, 2015
    Applicant: Lucigen Corporation
    Inventors: Ronald Godiska, David A. Mead, Nikolai V. Ravin
  • Linear vectors, host cells and cloning methods
    Patent number: 9029134
    Abstract: Linear vectors derived from bacteriophage of E. coli and host cells suitable for cloning are provided. The linear vectors include a left arm comprising a left telomere and a first selectable marker, a right arm comprising a right telomere and a second selectable marker and a cloning region located between the left arm and the right arm. Optional further components of the vector include transcriptional termination sequences, multiple cloning sites and reporter stuffer regions.
    Type: Grant
    Filed: January 12, 2007
    Date of Patent: May 12, 2015
    Assignee: Lucigen Corporation
    Inventors: Ronald Godiska, David A. Mead, Nikolai V. Ravin
  • LINEAR VECTORS, HOST CELLS AND CLONING METHODS
    Publication number: 20090263873
    Abstract: Linear vectors derived from bacteriophage of E. coli and host cells suitable for cloning are provided. The linear vectors include a left arm comprising a left telomere and a first selectable marker, a right arm comprising a right telomere and a second selectable marker and a cloning region located between the left arm and the right arm. Optional further components of the vector include transcriptional termination sequences, multiple cloning sites and reporter stuffer regions.
    Type: Application
    Filed: January 12, 2007
    Publication date: October 22, 2009
    Applicant: LUCIGEN CORPORATION
    Inventors: Ronald Godiska, David A. Mead, Nikolai V. Ravin